Myeloid CD209 Drives Tumor Immune Evasion and Resistance to PD-1 Blockade Through ICAM-2–Mediated T-Cell Mechanosuppression

Resistance to PD-1–based immunotherapy remains a major challenge in cancer treatment, especially in immunologically “cold” tumors characterized by T-cell exclusion and impaired T-cell effector function. Mechanical processes impact T-cell activity, and mechanical perturbations may represent a distinct mode of immune suppression. Here, we identified CD209, a myeloid-expressed C-type lectin receptor, as a mechanosuppressive regulator of antitumor T-cell immunity. CD209 was selectively enriched in tumor-infiltrating M2-like macrophages and monocytes, and elevated CD209 expression was associated with poor clinical response to PD-1 blockade and immune dysfunction and exclusion across multiple cancer types. Mechanistically, CD209 directly engaged ICAM-2 on T cells and activated ROCK1–ERM signaling. This interaction increased T-cell cortical stiffness, destabilized T cell–antigen presenting cell interactions, and attenuated T-cell receptor signaling. Blocking the CD209–ICAM-2–ERM pathway restored T-cell activation and promoted CD8+ T-cell infiltration and effector function in both in vivo mouse models and ex vivo human tumor systems. Importantly, CD209 blockade enhanced the response to PD-1 inhibition and overcame resistance to PD-1–based immunotherapy in refractory and immunologically “cold” tumor models. Together, these findings define a myeloid-derived mechanical immune checkpoint and reveal T-cell mechanosuppression as a targetable mechanism of tumor immune evasion and immunotherapy resistance.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-11-19
DOI
https://doi.org/10.1158/0008-5472.can-26-2612
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Myeloid CD209 Drives Tumor Immune Evasion and Resistance to PD-1 Blockade Through ICAM-2–Mediated T-Cell Mechanosuppression

Ce Wang, Xue Xiao, Guoling Huang, Ming Yi et al.
1 links
Cancer Research
Cancer Immunotherapy and Biomarkers
article

Myeloid CD209 Drives Tumor Immune Evasion and Resistance to PD-1 Blockade Through ICAM-2–Mediated T-Cell Mechanosuppression

Ce Wang, Xue Xiao, Guoling Huang, Ming Yi, Ting Pan, Lingyun Feng, Zhen Li, Yangyang Li, Xi Li, Yanyun Du, Panyin Shu, Jiaqi Wu, Ruirui He, Bo Zeng, Zhihui Cui, Yuan Wang, Heping Wang, Tingting Wang
article en

Abstract

Resistance to PD-1–based immunotherapy remains a major challenge in cancer treatment, especially in immunologically “cold” tumors characterized by T-cell exclusion and impaired T-cell effector function. Mechanical processes impact T-cell activity, and mechanical perturbations may represent a distinct mode of immune suppression. Here, we identified CD209, a myeloid-expressed C-type lectin receptor, as a mechanosuppressive regulator of antitumor T-cell immunity. CD209 was selectively enriched in tumor-infiltrating M2-like macrophages and monocytes, and elevated CD209 expression was associated with poor clinical response to PD-1 blockade and immune dysfunction and exclusion across multiple cancer types. Mechanistically, CD209 directly engaged ICAM-2 on T cells and activated ROCK1–ERM signaling. This interaction increased T-cell cortical stiffness, destabilized T cell–antigen presenting cell interactions, and attenuated T-cell receptor signaling. Blocking the CD209–ICAM-2–ERM pathway restored T-cell activation and promoted CD8+ T-cell infiltration and effector function in both in vivo mouse models and ex vivo human tumor systems. Importantly, CD209 blockade enhanced the response to PD-1 inhibition and overcame resistance to PD-1–based immunotherapy in refractory and immunologically “cold” tumor models. Together, these findings define a myeloid-derived mechanical immune checkpoint and reveal T-cell mechanosuppression as a targetable mechanism of tumor immune evasion and immunotherapy resistance.

Cancer Research
University of Electronic Science and Technology of China (CN), Soochow University (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation, Department of Science and Technology of Sichuan Province, National Science Fund for Distinguished Young Scholars
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon